NCT06946914 Misoprostol Before Caesarean Section
| NCT ID | NCT06946914 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Kafrelsheikh University |
| Condition | Misoprostol |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 160 participants in total. It began in 2024-06-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Eligibility Criteria
Inclusion Criteria: * Women with indication for elective caesarean section. * Age less than 35 years old. * Gestational age less than 38 weeks. * Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length. * Singleton pregnancy with no major anomalies Exclusion Criteria: * Any obstetric disorders as preeclampsia and diabetes. * Fetus with oligohydramnios, intrauterine growth restriction. * Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia. * History of more than or equal 2 previous caesarean section.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06946914 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 35 Years, studying Misoprostol. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06946914 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06946914 currently recruiting?
Yes, NCT06946914 is actively recruiting participants. Contact the research team at mernaashraf2551996@gmail.com for enrollment information.
Where is the NCT06946914 trial being conducted?
This trial is being conducted at Kafr Ash Shaykh, Egypt, Egypt.
Who is sponsoring the NCT06946914 clinical trial?
NCT06946914 is sponsored by Kafrelsheikh University. The trial plans to enroll 160 participants.